As of April 2024 Protalix BioTherapeutics has a market cap of $84 Million. This makes Protalix BioTherapeutics the world's 7479th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $84 M | -35.3% |
2023 | $0.12 B | 87.08% |
2022 | $69.41 M | 83.2% |
2021 | $37.88 M | -68.69% |
2020 | $0.12 B | 148.64% |
2019 | $48.66 M | 5.47% |
2018 | $46.14 M | -50.05% |
2017 | $92.38 M | 67.73% |
2016 | $55.08 M | -45.89% |
2015 | $0.10 B | -40.9% |
2014 | $0.17 B | -52.64% |
2013 | $0.36 B | -25.05% |
2012 | $0.48 B | 14.95% |
2011 | $0.42 B | -47.68% |
2010 | $0.80 B | 50.76% |
2009 | $0.53 B | 283.05% |
2008 | $0.13 B | -45.77% |
2007 | $0.25 B | -75.03% |
2006 | $1.03 B | 4063.51% |
2005 | $24.78 M | 4150% |
2004 | $0.58 M | -50% |
2003 | $1.16 M | 263.64% |
2002 | $0.32 M | -52.17% |
2001 | $0.67 M |
On Apr 19th, 2024 the market cap of Protalix BioTherapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $147.22 B | 175,148.41% | ๐บ๐ธ USA |
Neurocrine Biosciences
NBIX | $13.27 B | 15,703.56% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | $3.13 B | 3,630.53% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $14.56 B | 17,238.13% | ๐ฎ๐ฑ Israel |